ClinicalTrials.Veeva

Menu

Predictive Value of Procalcitonin for Bacteremia in the ICU

R

Rijnstate Hospital

Status

Completed

Conditions

Procalcitonin
Sepsis

Treatments

Diagnostic Test: procalcitonin measurement

Study type

Observational

Funder types

Other

Identifiers

NCT03497741
2016-0877

Details and patient eligibility

About

Association between plasma procalcitonin levels and positive blood cultures in critical illness patients in the ICU.

Full description

Rationale: Association of procalcitonin levels and blood cultures in critical illness patients on the ICU.

Objective: Procalcitonin is an acute phase protein. As part of the acute phase response, procalcitonin is produced during sepsis. Previous research shows that procalcitonin is a biomarker for bloodstream infection. However, there is still little known about the value of procalcitonin in diagnostics for micro-organism underlying a sepsis in ICU patients. In modern practice, blood cultures are taken when a patient is septic to determine the responsible micro-organism. When procalcitonin is a predictive value for bacteremia in the ICU, the number of blood cultures can be reduced.

Study design: An observational cohort study intervention: for each patient in the ICU blood cultures were taken, the procalcitonin level was determined. During 6 months 150 patients will be included.

Main study parameters/endpoints: this study will examine the predictive value of procalcitonin in blood cultures on the ICU.

Enrollment

170 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients admitted to the ICU
  • Age > 18 years

Exclusion criteria

  • Hemodialysis/ Continuous Veno-Venous Hemofiltration

Trial contacts and locations

1

Loading...

Central trial contact

D Hoogeveen

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems